Abstract
Mice infected with Brucella melitensis were treated with streptomycin, co-trimoxazole, ciprofloxacin, doxycycline, and rifampin intraperitoneally and with ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin orally for 14 to 21 days. Doxycycline- and rifampin-treated animals (either route) demonstrated a cure rate significantly better than that of controls. Longer therapy periods were associated with a significantly better outcome. Therapy failure was observed in all mice treated with ciprofloxacin, ofloxacin, and pefloxacin administered orally as well as in mice treated intraperitoneally with ciprofloxacin. Our findings demonstrate that treatment of experimental brucellosis in mice with doxycycline and rifampin yields therapeutic results that are superior to those yielded by treatment with quinolones.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BRAUDE A. I., SPINK W. W. The action of aureomycin and other chemotherapeutic agents in experimental brucellosis. J Immunol. 1950 Aug;65(2):185–199. [PubMed] [Google Scholar]
- Fountain M. W., Weiss S. J., Fountain A. G., Shen A., Lenk R. P. Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides. J Infect Dis. 1985 Sep;152(3):529–535. doi: 10.1093/infdis/152.3.529. [DOI] [PubMed] [Google Scholar]
- Hall W. H. Modern chemotherapy for brucellosis in humans. Rev Infect Dis. 1990 Nov-Dec;12(6):1060–1099. doi: 10.1093/clinids/12.6.1060. [DOI] [PubMed] [Google Scholar]
- Lang R., Raz R., Sacks T., Shapiro M. Failure of prolonged treatment with ciprofloxacin in acute infections due to Brucella melitensis. J Antimicrob Chemother. 1990 Dec;26(6):841–846. doi: 10.1093/jac/26.6.841. [DOI] [PubMed] [Google Scholar]
- Philippon A. M., Plommet M. G., Kazmierczak A., Marly J. L., Nevot P. A. Rifampin in the treatment of experimental brucellosis in mice and guinea pigs. J Infect Dis. 1977 Oct;136(4):481–488. [PubMed] [Google Scholar]
- Philippon A., Kazmierczak A., Névot P. Traitement de la brucellose de la souris par les antibiotiques (tétracycline, ampicilline, triméthoprime-sulfaméthoxazole) en association avec Corynebacterium parvum. Ann Inst Pasteur (Paris) 1972 Sep;123(3):349–362. [PubMed] [Google Scholar]
- Philippon A., Kazmierczak A., Plommet M., Marly J., Nevot P. Traitement de la brucellose expérimentale de la souris et du cobaye par la rifampicine. Dev Biol Stand. 1976;31:279–286. [PubMed] [Google Scholar]
- Philippon A., Kazmierczak A. Rifampicine et tétracycline dans le traitement de la brucellose expérimentale de la souris. Ann Inst Pasteur (Paris) 1972 Sep;123(3):459–462. [PubMed] [Google Scholar]
- Rubinstein E., Lang R., Shasha B., Hagar B., Diamanstein L., Joseph G., Anderson M., Harrison K. In vitro susceptibility of Brucella melitensis to antibiotics. Antimicrob Agents Chemother. 1991 Sep;35(9):1925–1927. doi: 10.1128/aac.35.9.1925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SHAFFER J. M., KUCERA C. J., SPINK W. W. Evaluation of prolonged antibiotic therapy in mice with chronic Brucella infection due to Brucella melitensis. J Immunol. 1953 Jan;70(1):31–38. [PubMed] [Google Scholar]